WELLS FARGO & COMPANY/MN - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 56 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$52,841
-60.5%
28,257
-47.0%
0.00%
Q2 2023$133,728
+1361.3%
53,278
+918.9%
0.00%
Q1 2023$9,151
-62.3%
5,229
-8.4%
0.00%
Q4 2022$24,251
-3.0%
5,706
-73.0%
0.00%
Q3 2022$25,000
+19.0%
21,100
+1.0%
0.00%
Q2 2022$21,000
-80.4%
20,900
-52.0%
0.00%
Q1 2022$107,000
-52.9%
43,586
-48.4%
0.00%
Q4 2021$227,000
-74.4%
84,486
-52.3%
0.00%
Q3 2021$886,000
+123.2%
177,060
+233.0%
0.00%
Q2 2021$397,000
+31.5%
53,165
+3.4%
0.00%
Q1 2021$302,000
+42.5%
51,400
+14.2%
0.00%
Q4 2020$212,000
+76.7%
45,000
+28.6%
0.00%
Q3 2020$120,00035,0000.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders